Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ENZC Enzolytics Inc (PK)

0.0024 (13.87%)
Last Updated: 12:09:49
Delayed by 15 minutes


Draw Mode:

Volume 3,298,931
Bid Price 0.0194
Ask Price 0.0197
News -
Day High 0.02


52 Week Range


Day Low 0.0169
Company Name Stock Ticker Symbol Market Type
Enzolytics Inc (PK) ENZC OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0024 13.87% 0.0197 12:09:49
Open Price Low Price High Price Close Price Prev Close
0.0173 0.0169 0.02 0.0173
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
123 3,298,931 $ 0.018557 $ 61,218 - 0.01 - 0.132
Last Trade Time Type Quantity Stock Price Currency
12:09:49 36,649 $ 0.0197 USD

Enzolytics Inc (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
63.46M 3.01B -1.98B 0 -2.94M -0.00 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Enzolytics (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No ENZC Message Board. Create One! See More Posts on ENZC Message Board See More Message Board Posts

Historical ENZC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.01360.020.0130.01607294,333,3150.006144.85%
1 Month0.01620.020.01270.01510364,440,4410.003521.60%
3 Months0.0230.02470.010.01591477,697,906-0.0033-14.35%
6 Months0.0430.060250.010.02495586,969,424-0.0233-54.19%
1 Year0.0570.1320.010.04574158,250,872-0.0373-65.44%
3 Years0.65990.65990.010.128780312,638,891-0.6402-97.01%
5 Years0.0010.9580.00010.069552126,853,1630.01871,870.00%

Enzolytics (PK) Description

Business Description Enzolytics, Inc. (the "Company" or "ENZC") is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. The Company is committed to creating drugs for the better health of mankind. ENZC's flagship compound ITV-1 is a suspension of Inactivated Pepsin Fragment (IPF), which studies have shown is effective in the treatment of HIV. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system. IPF is a platform technology that can be used to facilitate a broad range of applications. It is free from major neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals in use today. IPF has not shown to be subject to viral resistance and is cost effective.

Your Recent History

Delayed Upgrade Clock